$SIGA
SIGA Technologies Inc
PRICE
$23.2 ▼-6.338%
Last Close
VOLUME
6,759,703
DAY RANGE
24.13 - 25.72
52 WEEK
5.49 - 26.99
Join Discuss about SIGA with like-minded investors
@singletary #StockTraders.NET
$VERU thats why you prepare. exact same as siga a few days back
3 Replies 2 👍 3 🔥
@danny4259 #StockTraders.NET
Good timing on your covers. > @singletary said: $SIGA target was low 23. made it most of the way. will watch veru thru the week and next for same setup
29 Replies 7 👍 12 🔥
@singletary #StockTraders.NET
$SIGA target was low 23. made it most of the way. will watch veru thru the week and next for same setup
16 Replies 7 👍 11 🔥
@singletary #StockTraders.NET
can not be a rider and oh its almost top. $SIGA $VERU $BBBY $NVTA all will end you
25 Replies 10 👍 10 🔥
@singletary #StockTraders.NET
yupp now we wait and will have $SIGA unwind later on. wil watch everyday. not mentioning it tho.
16 Replies 12 👍 12 🔥
Key Metrics
Market Cap
1.78 B
Beta
0.90
Avg. Volume
19.81 M
Shares Outstanding
73.02 M
Yield
0%
Public Float
0
Next Earnings Date
2022-11-03
Next Dividend Date
Company Information
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company focused on the health security market. Health security comprises countermeasures for biological, chemical, radiological and nuclear attacks (biodefense market), vaccines and therapies for emerging infectious diseases, and health preparedness. Its lead product is TPOXX®, also known as tecovirimat and ST-246®, an orally administered and IV formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. TPOXX is a novel small-molecule drug and the US maintains a stockpile of 1.7 million oral courses in the Strategic National Stockpile under Project BioShield. The oral formulation of TPOXX was approved by the FDA for the treatment of smallpox on July 13, 2018. In September 2018, SIGA signed a contract with Biomedical Advanced Research and Development Authority (BARDA) for additional procurement and development related to both oral and intravenous formulations of TPOXX.
Website: www.siga.com
HQ: ,
Related News